Drugmakers Race to Challenge Novo Nordisk and Eli Lilly's Obesity Drug Dominance
Pharmaceutical companies bet on new approaches to crack into the lucrative weight loss market currently controlled by two industry giants.
Read the full reporting at CNBC Markets.
Originally reported by CNBC Markets.